Proscia has made its Concentriq Dx digital pathology software available for use in reviewing and reporting of digital pathology slides in the United States. In Europe, Concentriq Dx is CE-marked for use in primary diagnosis. In the United States, the software will support the need for remote pathology brought about by the COVID-19 pandemic. The company’s announcement comes as FDA has issued new guidance aimed at expanding the availability of remote digital pathology devices.
New to digital pathology? Learn how whole slide imaging is changing the industry here.